Search database
LIST OPTIONS
Filter
10
Filtered Results: 10
Text search: N. B. Bellareet
Featured
Language
Document type
Studies & Reports
4
No document type
3
Guidelines
2
Fact sheets
1
Countries / Regions
Sierra Leone
1
Guinea
1
Africa
1
Germany
1
Liberia
1
India
1
Authors & Publishers
World Health Organization WHO
3
J Acquir Immune Defic Syndr
2
Wolters Kluwer Health
2
C. C. Chakanyuka Musanhu al.
1
C. Mpody, et al.
1
et al.
1
J. M. Humphrey
1
Journal of Virus Eradication
1
L. L. Abuogi
1
M. Newman Owiredu
1
N. B. Bellareet
1
N. Bellare
1
N. C. Rollins
1
National AIDS
1
Robert-Koch-Institut RKI
1
S. M. Essajee
1
UN Mission for Ebola Emergency Response
1
World Health Organisation (WHO)
1
Publication Years
Category
COVID-19
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
HIV & STI
1
Toolboxes
Prevention of mother-to-child transmission (PMTCT)
2
Hand Hygiene
1
Maps
1
Hand Hygiene
1
Diagnostics & Laboratory Guidance
1
Surveillance & Contact tracing
1
Country specific documents
1
Gender Aspects
1
Immunization Guidelines
1
Hand Hygiene
1
Studies & Reports
1
Women
1
Reports & Studies
1
Eastern and Southern Africa
1
Supplement Article J Acquir Immune Defic Syndr  Volume 75, Supplement 2, June 1, 2017 www.jaids.com
Supplement Article J Acquir Immune Defic Syndr  Volume 75, Supplement 2, June 1, 2017 Building Health Systems through Implementation Research Published by Wolters Kluwer Health, Inc.
Probenmaterial für die PCR-Diagnostik zum direkten Erregernachweis Verpackung und Versand Empfehlungen zum Umgang mit Probenmaterial Direkter Erregernachweis durch RT-PCR Antikörpernachweise (indirekter Nachweis einer Infektion) Antigennachweise Bemerkungen zur Interp... more
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn... more
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance. WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci... more
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Hand hygiene is vital for safe health care delivery, yet practices at the point of care remain suboptimal worldwide. A comprehensive research agenda is therefore necessary to improve our understanding of factors influencing hand hygiene behaviour and to strengthen appropriate interventions. This age... more